NOW:53208:USA01012
http://widgets.journalinteractive.com/cache/JIResponseCacher.ashx?duration=5&url=http%3A%2F%2Fdata.wp.myweather.net%2FeWxII%2F%3Fdata%3D*USA01012
64°
H 66° L 64°
Foggy | 0MPH

Enzyme Replacement Therapy Shows Promising Results in X-Linked Myotubular Myopathy

Jan. 24, 2013

A collaborative research team including a Medical College of Wisconsin (MCW) pediatric neuropathologist successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy from 4s3 Bioscience.

The findings are published in the January edition of Human and Molecular Genetics http://hmg.oxfordjournals.org/content/early/2013/01/09/hmg.ddt003.full.pdf+html.

X-linked myotubular myopathy (XLMTM) is a severe muscle disease caused by an absence of a protein called myotubularin. There is currently no treatment for this disorder, and most patients die in infancy or childhood. The overall incidence of myotubular myopathy is 1 in 50,000 live male births.

Michael W. Lawlor, MD, PhD, assistant professor of pathology at MCW, researcher at the Children’s Hospital of Wisconsin Research Institute, and director of the pediatric pathology neuromuscular laboratory in MCW’s division of pediatric pathology, coordinated a study at Boston Children’s Hospital and MCW that used targeted enzyme replacement therapy to deliver myotubularin to muscles of mice with XLMTM. After two weeks of treatment, the mice showed marked improvement in muscle function and pathology.

“These promising findings suggest that even low levels of myotubularin protein replacement can not only improve weakness in patients, but also at least partially reverse the structural abnormalities seen in XLMTM,” said Dr. Lawlor. “The next step is to determine appropriate dosage, and toxicity, before we venture into human trials,” he continued.

The study was supported by the National Institutes of Health, the Muscular Dystrophy Association, the Joshua Frase Foundation, and the Lee and Penny Anderson Family Foundation.

Co-authors of the study are Dustin Armstrong and Michael O’Callaghan from 4s3 Bioscience, Inc.; Marissa Viola, Cynthia P. Hsu, and Alan H. Beggs from Boston Children’s Hospital and Harvard Medical School; Jeffrey J. Widrick from Spaulding Rehabilitation Hospital; Hui Meng from MCW; Robert W. Grange from Virginia Tech; Martin Childers from Wake Forest University; Christopher R. Pierson from Nationwide Children’s Hospital; and Anna Buj-Bello from INSERM.

The efforts of Drs. Armstrong, Beggs, and Lawlor began while Dr. Lawlor was working for Dr. Beggs at Boston Children’s Hospital, and this collaborative effort has continued at Dr. Lawlor’s lab at MCW. As studies progress, Dr. Lawlor will continue to perform pathological analyses on research tissue from preclinical studies with the 4s3 Bioscience replacement enzyme and assist in further elucidating the pathophysiology of XLMTM. This work by Dr. Lawlor’s laboratory utilizes resources partially supported and available through the Children’s Research Institute’s Imaging Core Facility.

This site uses Facebook comments to make it easier for you to contribute. If you see a comment you would like to flag for spam or abuse, click the "x" in the upper right of it. By posting, you agree to our Terms of Use.

Suburban News Roundup

E-mail Newsletter

Your link to the biggest stories in the suburbs delivered Thursday mornings.


Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter
Get the Newsletter!

Login or Register to manage all your newsletter preferences.

Community Watch

» Initial Reaction Podcast: Just how much of a chance do the Wisconsin Badgers have? 9/3

» Updated week three rankings of area prep football teams and players 9/3

» Wauwatosa police will host OWI Task Force deployment 9/2

» WauwaTiki, the tiki bar planned in Tosa, is projecting a November opening 9/2

» Sport Shorts: Sept. 3, 2015 9/2

» Despite loss, Wauwatosa East's defense continues to shine 9/2

» Wauwatosa West football team beats Grafton to start season 2-0 once again 9/2

» Wauwatosa West girls volleyball team takes second at Early Bird tournament 9/2

» Wauwatosa West boys soccer team goes 1-1-1 at Muskego Quad 9/2

» Wauwatosa West girls tennis team nips Vikings 9/2

» Wauwatosa East boys cross-country team has good week 9/2

» Hazardous waste collection event sets Sept. 12 date 9/1

» Tosa Green Summit returns Sept. 12 9/1

» Call for Taste of Tosa cupcake and chili registrants 9/1

» Get interesting prep football tidbits and insights with 'First and Short' blog 8/28

» Hundreds of Tosa residents experienced short power outage Aug. 27 8/28

» Wauwatosa Village valet service tentatively halted on Sundays 8/27

» Wauwatosa East girls cross-country team looking for good things 8/26

» Wauwatosa West returnees should help girls cross-country team 8/26

» Wauwatosa East tennis team has nine returning players 8/26

» Wauwatosa West girls volleyball team has holes to fill 8/26

» Wauwatosa girls golf team fourth at first GMC mini-meet 8/26

» Potter to lead Wauwatosa East boys cross-country team 8/26

» Suspected pipe bomb draws neighborhood attention in Wauwatosa Updated:  8/24

» Carey, defense spark New Berlin Eisenhower win 8/24

View All Posts Got a tip? Welcome rss

Advertisement

Advertisement

Hidden Tosa

 

"Hidden Tosa" is a semi-regular feature where reporter Rory Linnane explores the closed down and closed off parts of Wauwatosa.

Advertisement

Local Business Directory

CONNECT